Photodynamic therapy with verteporfin for anterior segment neovascularizations in neovascular glaucoma

American Journal of Ophthalmology

Volumn 138, Issue 1, 2004, Pages 157-158

  Parodi, Maurizio Battaglia ^a,b   Iacono, Pierluigi ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b MAGGIORE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; TIMOLOL;

ADULT; AGED; ANTERIOR EYE CHAMBER ANGLE; ARTICLE; CASE REPORT; CLINICAL TRIAL; CONTACT LENS; HUMAN; INTRAOCULAR PRESSURE; IRIS DISEASE; NEOVASCULAR GLAUCOMA; NEOVASCULARIZATION (PATHOLOGY); PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; SYMPTOM; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTERIOR EYE SEGMENT; FLUORESCEIN ANGIOGRAPHY; GLAUCOMA, NEOVASCULAR; HUMANS; INTRAOCULAR PRESSURE; IRIS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; TREATMENT OUTCOME;

EID: 3042784822     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2004.02.015     Document Type: Article

References (5)

1. Tripathi R.C., Li J., Tripathi B.J., Chalam K.V., Adamis A.P. Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. Ophthalmology. 105:1998;232-237
2. Miller J.W., Stinson W.G., Gregory W.A., El-Koumy H.A., Puliafito C.A. Phtalocyanine photodynamic therapy of experimental iris neovascularization. Ophthalmology. 98:1991;1711-1719
3. Husain D., Miller J.W., Kenney A.G., Michaud N., Flotte T.J., Gragaudas E.S. Photodynamic therapy and digital angiography of experimental iris neovascularization using liposomal benzoporphyrin derivative. Ophthalmology. 104:1997;1242-1250
4. Wand M., Dueker D.K., Aiello L.M., Grant W.M. Effects of panretinal photocoagulation on rubeosis iridis, angle neovascularization, and neovascular glaucoma. Am J Ophthalmol. 86:1978;332-339
5. La Muraglia G.M., Adili F., Karp S.J., Statius van Eps R.G., Watkins M.T. Photodynamic therapy inactivates extracellular matrix-basic fibroblast growth factor insight to its effect on the vascular wall. J Vasc Surg. 26:1997;294-301